These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10523097)

  • 1. Screening and mortality from cervical cancer. Study shows importance of centralised organisation in screening.
    Adab R; McGhee S; Hedley A
    BMJ; 1999 Sep; 319(7210):642-3. PubMed ID: 10523097
    [No Abstract]   [Full Text] [Related]  

  • 2. Harms and benefits of screening to prevent cervical cancer.
    Murphy MF; Neale R
    Lancet; 2004 Oct 23-29; 364(9444):1484-5; author reply 1485-6. PubMed ID: 15500883
    [No Abstract]   [Full Text] [Related]  

  • 3. Deaths from cervical cancer began falling before screening programmes were established.
    Raffle AG
    BMJ; 1997 Oct; 315(7113):953-4. PubMed ID: 9361567
    [No Abstract]   [Full Text] [Related]  

  • 4. An epidemic averted through medical screening.
    Austin H
    J Med Screen; 2005; 12(1):1-2. PubMed ID: 15814012
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening has halved incidence of cervical cancer in UK.
    Kmietowicz Z
    BMJ; 2009 Feb; 338():b807. PubMed ID: 19240091
    [No Abstract]   [Full Text] [Related]  

  • 6. Computerisation of screening for cervical cancer. The OCCURS Group.
    Health Bull (Edinb); 1988 May; 46(3):146-52. PubMed ID: 3182253
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential impact of a prophylactic vaccine for human papillomavirus on the current cervical screening programme in Hong Kong.
    Koljonen PA
    Hong Kong Med J; 2007 Aug; 13(4):304-10. PubMed ID: 17664535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast and cervical cancer screening programme implementation in 16 countries.
    Dowling EC; Klabunde C; Patnick J; Ballard-Barbash R;
    J Med Screen; 2010; 17(3):139-46. PubMed ID: 20956724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons that some screening programmes fail to control cervical cancer.
    Chamberlain J
    IARC Sci Publ; 1986; (76):161-8. PubMed ID: 3570402
    [No Abstract]   [Full Text] [Related]  

  • 10. New tests in cervical screening.
    Raffle AE
    Lancet; 1998 Jan; 351(9098):297. PubMed ID: 9457130
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
    Kim JJ; Leung GM; Woo PP; Goldie SJ
    J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for cervical cancer: revised policy. The recommendations of the DHSS Committee on Gynaecological Cytology.
    Draper GJ
    Health Trends; 1982 May; 14(2):37-40. PubMed ID: 10258580
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical screening: the potential contribution of workplace examinations.
    Morris GJ
    Health Bull (Edinb); 1988 May; 46(3):156-9. PubMed ID: 3182255
    [No Abstract]   [Full Text] [Related]  

  • 15. Organisation of a programme for cervical cancer screening. ICRF coordinating committee on cervical screening.
    Br Med J (Clin Res Ed); 1984 Oct; 289(6449):894-5. PubMed ID: 6434132
    [No Abstract]   [Full Text] [Related]  

  • 16. [Importance of cancer of the cervix in Cataluña: considerations on an eventual screening program].
    Spagnolo de la Torre E; Segura Benedicto A; Vila Macau R; Andrés Martínez J; Sans Menéndez S
    Med Clin (Barc); 1984 Jan; 82(2):83-6. PubMed ID: 6708615
    [No Abstract]   [Full Text] [Related]  

  • 17. Lessons from a cervical screening programme: are they transferable?
    Fleischl J
    Nurs Prax N Z; 1993 Jul; 8(2):34-7. PubMed ID: 8364340
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the impact of screening for cancer of the cervix.
    Miller AB
    IARC Sci Publ; 1986; (76):149-60. PubMed ID: 3570400
    [No Abstract]   [Full Text] [Related]  

  • 19. High-risk groups and cervical cancer.
    Br Med J; 1980 Sep; 281(6241):629-30. PubMed ID: 7437742
    [No Abstract]   [Full Text] [Related]  

  • 20. Who receives, benefits from and is harmed by cervical and breast cancer screening among Hong Kong Chinese?
    Leung GM; Woo PP; Cowling BJ; Tsang CS; Cheung AN; Ngan HY; Galbraith K; Lam TH
    J Public Health (Oxf); 2008 Sep; 30(3):282-92. PubMed ID: 18482996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.